Merck KGaA

Avelumab

Biodrugs/ Drugs
Cancer
anti-PD-L1 mAb. Several types of cancer (Merkel cell cancer 1L / urothelial cancer / solid tumors and non-small cell lung cancer 1L in combination with talazoparib, axitinib, ALK inhibitors, cetuximab, or chemotherapy).
2Phase II in Spain, 1Phase I in Spain